FAES FARMA, S.A.

Consensus Faes Farma, S.A.

Equities

FAE

ES0134950F36

Market Closed - BME Other stock markets 11:35:27 2024-05-07 am EDT			5-day change	1st Jan Change
3.5 ^EUR	+0.43%		+3.55%	+10.76%

Apr. 26	FAES FARMA : Q1 beat; full-year guidance re-affirmed
Apr. 15	Faes Farma, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Faes Farma, S.A.

Price target over the last 5 years

History of analyst recommendation changes

55.QYKekyMupFv-V7jaRpRif0rJcsaYQZDN4gykj56JzPs.N7HZ600elyPNO--WJ9s3M3yTCLP6I_a1pXTg587LiJoU98rkaxuXIcY0zw~ec79a86dd41cceb55bc7b4b9684fac0e

Analyst Recommendations on Faes Farma, S.A.

FAES FARMA : Q1 beat; full-year guidance re-affirmed	Apr. 26
FAES FARMA : Q4 profitability exceeded expectations	Feb. 27
FAES FARMA : Mixed Q3; markets need more from Faes to be convinced	23-10-25
FAES FARMA : A soft Q2, as expected; guidance maintained	23-08-01
FAES FARMA : Increased R&D focus and inflationary pressures to hold back near-to-medium term earnings	23-07-12
FAES FARMA : A healthy start to 2023	23-05-08
FAES FARMA : 2022 guidance met + positive view maintained	23-03-06
Roche’s Alzheimer’s failure has sector-wide implications	22-11-14
FAES FARMA : Soft Q3, but 2022 guidance maintained	22-10-28
FAES FARMA : Another stronger quarter but maintained full-year outlook	22-08-01
FAES FARMA : Strong Q1; but some moderation lies ahead	22-05-02
FAES FARMA : A strong Q4 sums up a decent 2021	22-03-02
FAES FARMA : An overall strong Q3	21-11-02
FAES FARMA : Base business recovers in Q2; FY21 outlook reiterated despite resurfacing COVID-19 concerns	21-07-28
TODAY'S ANALYST RECOMMENDATIONS : Cisco, easyJet, L Brands, Mattel, Salesforce...	21-05-21
FAES FARMA : Q1 21 – a mixed bag	21-05-04
FAES FARMA : Bilastine weighed on FY20; capacity expansion to cater underlying demand	21-03-03

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

4

Last Close Price

3.5 EUR

Average target price

3.708 EUR

Spread / Average Target

+5.93%

High Price Target

4.33 EUR

Spread / Highest target

+23.71%

Low Price Target

3.2 EUR

Spread / Lowest Target

-8.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Faes Farma, S.A.

alphavalue

Abhishek Raval

Ratings for Faes Farma, S.A.

Trading Rating

Investor Rating

ESG Refinitiv

B

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Stock Market
Equities
FAE Stock
Consensus Faes Farma, S.A.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW